| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d269c8e41f178194d858c230c9f85e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-32 |
| filingDate |
1981-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1981-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2068950-A |
| titleOfInvention |
Pyridine Derivatives |
| abstract |
Pyridine thromboxane synthetase inhibitors have the formula: <IMAGE> wherein m is 0 or 1; X is O or S; Y is either (a) -(CH2)n- wherein n is 0 or an integer of from 1 to 5 or (b) a 5- or 6-membered heterocyclic group; R<1> is hydrogen or a C1-C4 alkyl group; and R<2> is a polar group, provided that when Y is isoxazolyl, R<2> may also be methyl. The compounds may be converted to their pharmaceutically acceptable acid addition salts and/or formulated as pharmaceutical compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0098690-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0111997-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4778803-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0229660-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0111997-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0229660-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0098690-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0099685-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0099685-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4789745-A |
| priorityDate |
1980-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |